Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 801 - 900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 801 | 26839834 |
US |
53 | 2 |
Dermatitis atopic, Pruritus, Dry skin, Skin fissures, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 802 | 26839838 |
US |
60 | 2 |
Dermatitis atopic, Rash erythematous, Rash pruritic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 803 | 26840015 |
US |
57 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 804 | 26840038 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 805 | 26840053 |
US |
4 | 1 |
Dermatitis atopic, Rash, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 806 | 26840055 |
US |
59 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 807 | 26840264 |
US |
50 | 1 |
Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 808 | 26840297 |
US |
2 | |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 809 | 26840593 |
US |
2 | |
Dermatitis atopic, Blister, Skin irritation, |
||||
DUPILUMAB, ERGOCALCIFEROL, |
||||
| 810 | 26840605 |
US |
39 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 811 | 26840845 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 812 | 26840847 |
US |
65 | 2 |
Eyelid margin crusting, Dermatitis atopic, |
||||
DUPILUMAB, TIRZEPATIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 813 | 26840861 |
US |
63 | 2 |
Dermatitis atopic, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 814 | 26841381 |
US |
55 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 815 | 26841384 |
US |
23 | 1 |
Dermatitis atopic, Rash erythematous, |
||||
DUPILUMAB, ATOMOXETINE, METHYLPHENIDATE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE, CRISABOROLE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 816 | 26841682 |
US |
22 | 1 |
Dermatitis atopic, Dry skin, Pruritus, |
||||
DUPILUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, FEXOFENADINE HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, CETIRIZINE HYDROCHLORIDE, |
||||
| 817 | 26841685 |
US |
2 | |
Rash pruritic, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 818 | 26841686 |
US |
16 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 819 | 26841694 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 820 | 26841722 |
US |
65 | 2 |
Eyelid margin crusting, Dermatitis atopic, |
||||
DUPILUMAB, TIRZEPATIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 821 | 26841939 |
US |
74 | |
Dermatitis atopic, Eczema, Pruritus, Scar, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, ERGOCALCIFEROL, |
||||
| 822 | 26842046 |
US |
2 | |
Pruritus, Skin exfoliation, Dry skin, Rash, Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, AMLODIPINE BESYLATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIOTHYRONINE SODIUM, PROGESTERONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, ROFLUMILAST, |
||||
| 823 | 26842053 |
US |
77 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 824 | 26842093 |
US |
44 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 825 | 26842402 |
US |
||
Dermatitis atopic, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 826 | 26842445 |
US |
37 | 2 |
Dermatitis atopic, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 827 | 26842450 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 828 | 26842451 |
US |
43 | 1 |
Dermatitis atopic, Rash papular, Rash pruritic, Dry skin, Rash, Urticaria, Skin swelling, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 829 | 26842790 |
US |
1 | |
Illness, Dermatitis atopic, Erythema, Dry skin, |
||||
DUPILUMAB, FLUOCINOLONE ACETONIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 830 | 26842791 |
US |
24 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DESONIDE, |
||||
| 831 | 26842808 |
US |
70 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 832 | 26843262 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 833 | 26843296 |
US |
2 | |
Dermatitis atopic, Stress, |
||||
DUPILUMAB, |
||||
| 834 | 26843593 |
US |
46 | 2 |
Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, USTEKINUMAB, |
||||
| 835 | 26843594 |
US |
68 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 836 | 26843612 |
US |
11 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 837 | 26843852 |
EU |
26 | 2 |
Dermatitis atopic, |
||||
LEVONORGESTREL, |
||||
| 838 | 26843903 |
US |
30 | 2 |
Dry skin, Pruritus, Skin irritation, Dermatitis atopic, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, |
||||
| 839 | 26843905 |
US |
34 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 840 | 26844183 |
US |
30 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 841 | 26844906 |
US |
48 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 842 | 26834512 |
US |
47 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 843 | 26834726 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 844 | 26834933 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 845 | 26834946 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 846 | 26834949 |
US |
57 | 2 |
Lip pruritus, Oral discomfort, Urticaria, Asthma, Wheezing, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 847 | 26834958 |
US |
53 | 2 |
Dermatitis atopic, Pruritus, Swelling, |
||||
DUPILUMAB, |
||||
| 848 | 26834972 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 849 | 26834984 |
US |
42 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 850 | 26835212 |
US |
39 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 851 | 26835215 |
US |
2 | |
Dermatitis atopic, Rash, Rash erythematous, Pruritus, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, FAMOTIDINE, LEVOTHYROXINE SODIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, CETIRIZINE HYDROCHLORIDE, |
||||
| 852 | 26835225 |
US |
52 | 2 |
Dermatitis atopic, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 853 | 26835246 |
US |
1 | |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 854 | 26835336 |
US |
52 | |
Dermatitis atopic, Muscle twitching, Asthenia, Rash, Skin discomfort, Sleep disorder, Infection, Pyrexia, Hyperhidrosis, Pruritus, Drug ineffective, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 855 | 26835502 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 856 | 26835739 |
US |
2 | |
Pruritus, Haemorrhage, Rash, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, BIOTIN, CETIRIZINE HYDROCHLORIDE, |
||||
| 857 | 26835759 |
US |
69 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 858 | 26835770 |
US |
33 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 859 | 26836093 |
US |
2 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 860 | 26836096 |
US |
55 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 861 | 26836110 |
US |
24 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PSYLLIUM HUSK, ERGOCALCIFEROL, |
||||
| 862 | 26836113 |
US |
64 | 2 |
Dermatitis, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 863 | 26836117 |
US |
66 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 864 | 26836469 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 865 | 26836497 |
US |
18 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 866 | 26836504 |
US |
57 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 867 | 26836831 |
US |
25 | 2 |
Dermatitis atopic, Dry skin, Pruritus, Skin fissures, Skin exfoliation, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, GLYCERIN, DESONIDE, NORETHINDRONE ACETATE, NORETHINDRONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 868 | 26836849 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 869 | 26837215 |
US |
67 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 870 | 26837221 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 871 | 26837229 |
US |
31 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 872 | 26837242 |
US |
23 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 873 | 26837254 |
US |
2 | 1 |
Influenza, Pyrexia, Weight decreased, Dermatitis atopic, Therapeutic response shortened, Therapeutic response decreased, |
||||
DUPILUMAB, EPINEPHRINE, |
||||
| 874 | 26837265 |
US |
59 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 875 | 26837545 |
US |
38 | 2 |
Dermatitis atopic, Multiple allergies, |
||||
DUPILUMAB, |
||||
| 876 | 26837550 |
US |
24 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 877 | 26837564 |
US |
56 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 878 | 26837569 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 879 | 26837587 |
US |
26 | 2 |
Initial insomnia, Skin haemorrhage, Skin fissures, Skin weeping, Dry skin, Skin exfoliation, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 880 | 26837970 |
US |
8 | 2 |
Scratch, Skin wound, Dermatitis atopic, Rash erythematous, Skin swelling, Pruritus, |
||||
DUPILUMAB, |
||||
| 881 | 26837992 |
US |
31 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, FISH OIL, ERGOCALCIFEROL, |
||||
| 882 | 26838464 |
US |
64 | 2 |
Rash, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 883 | 26838481 |
US |
74 | 1 |
Scratch, Pain of skin, Skin burning sensation, Cough, Sneezing, Skin exfoliation, Rash, Pruritus, Dermatitis atopic, Drug ineffective, Inappropriate schedule of product administration, Product use issue, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, CETIRIZINE HCL, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, FEXOFENADINE HCL, CHLORPHENIRAMINE MALEATE, LORATADINE, FLUTICASONE PROPIONATE, CETIRIZINE HYDROCHLORIDE, DIPHENHYDRAMINE HCL 25 MG, ALLERGY RELIEF, TRIAMCINOLONE ACETONIDE, CETIRIZINE HCL 10 MG, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL, MOMETASONE FUROATE, LEVOCETIRIZINE DIHYDROCHLORIDE, ONION, APIS MELLIFERA, DROSERA ROTUNDIFOLIA, EUPHRASIA STRICTA, URTICA URENS, LORATADINE 10MG, CETIRIZINE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE 25MG, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL, ALLIUM CEPA, APIS MELLIFICA, ARALIA RACEMOSA, BLATTA ORIENTALIS, BOVISTA, CARDUUS MARIANUS, CHELIDONIUM MAJUS, EUPHRASIA OFFICINALAS, GALPHIMIA GLAUCA, HEDERA HELIX, HYDRASTIS CANADENSIS, LUFFA OPERCULATA, NASTURTIUM AQUATICUM, OKOUBAKA, SABADILLA, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE., FUROSEMIDE, FUROSEMIDE, HYDROXYZINE, HYDROXYZINE, LISINOPRIL, LISINOPRIL, |
||||
| 884 | 26838737 |
US |
47 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 885 | 26838738 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 886 | 26838743 |
US |
10 | 2 |
Weight abnormal, Pruritus, Dermatitis atopic, Incorrect dose administered, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 887 | 26838754 |
US |
2 | 1 |
Dermatitis atopic, Dermatitis, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 888 | 26838756 |
US |
15 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, |
||||
| 889 | 26838957 |
US |
2 | |
Dermatitis atopic, Eczema, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 890 | 26839247 |
1 | ||
Therapy change, Dermatitis atopic, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 891 | 26839407 |
US |
2 | 1 |
Dermatitis atopic, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 892 | 26839503 |
US |
8 | 1 |
Dermatitis atopic, Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 893 | 26843678 |
81 | 2 | |
Dermatitis atopic, Psoriasis, |
||||
LEBRIKIZUMAB-LBKZ, LISINOPRIL, ERGOCALCIFEROL, |
||||
| 894 | 26829755 |
US |
35 | 2 |
Hypersensitivity, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 895 | 26830173 |
US |
22 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 896 | 26830183 |
US |
31 | 2 |
Stress, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 897 | 26830369 |
US |
56 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 898 | 26830390 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 899 | 26830659 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 900 | 26830667 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30